Advanced Search
Contact | Corporate | Help

Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer

Sponsors:
  • Henry Ford Health System
  • Genentech
Phases:
  • Phase II
  • Phase III
IndicationsAcronym:
  • Head and Neck Cancer
  • Carcinoma, Squamous Cell
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Erlotinib
Enrollment:
6

Additional information about NCT00448240.


SourceSolution © 2008-2012